5455W-13 A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken at Bedtime in Patients with Fibromyalgia

Type of Study
Rheumatology - Fibromyalgia
Short Description

To evaluate the efficacy and safety of TNX-102 SL tablets taken at bedtime over 12 weeks of treatment using a numerical rating scale to assess average daily pain.

Status
Open
Principal Investigator
Philip J. Mease, MD
Eligibility Notes

You must meet the study requirements, including (but not limited to):

  • 18 to 65 years of age
  • Have a Fibromyalgia diagnosis
  • No diagnosis of Rheumatoid Arthritis or Lupus
  • No history of severe Sleep Apnea or use of CPAP machine
Contact Name
Sephren Barrow
Phone
206-386-26248
Email
sephren.barrow@swedish.org